Facebook
Twitter
Telegram
Report an ErrorVYNE Therapeutics Financial Ratios 2011-2024 | VYNE
Annual Financial Ratios VYNE Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.8 | -0.3 | -0.0 | -1.0 | - | - | - | - | - | - | - | - | - |
P/S |
51.6 | 16.3 | 3.1 | 12.2 | - | - | - | - | - | - | - | - | - |
EPS |
-2.8 | -7.3 | -25.6 | 7.9 | -3.1 | -2.4 | -5.7 | -2.8 | -1.0 | - | - | - | - |
EV (Enterprise Value) |
211 K | -13.8 M | -20.9 M | 255 M | -20.1 M | -40 M | 114 M | 67.5 M | 16 M | - | - | - | - |
EBITDA per Share |
- | -10.7 | -13.6 | -3.49 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-0.4 | -2.1 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | -0.03 | - | - | - | - | - | - | - | - | - | ||
P/B |
0.2 | 0.2 | 0.1 | 6.8 | - | - | - | - | - | - | - | - | - |
P/CF |
-0.9 | -0.3 | -0.1 | -1.9 | - | - | - | - | - | - | - | - | - |
ROE % |
-32.06 | -74.39 | -150.77 | -681.64 | - | - | - | - | - | - | - | - | - |
ROA % |
-29.13 | -56.95 | -109.37 | -272.63 | - | - | - | - | - | - | - | - | - |
ROCE % |
-32.46 | -109.91 | -80.00 | -156.97 | - | - | - | - | - | - | - | - | - |
Current Ratio |
10.9 | 4.4 | 3.6 | 4.1 | - | - | - | - | - | - | - | - | - |
DSO |
- | 2901.3 | 4587.4 | 275.0 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | 1941.4 | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 1253.4 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 2901.2 | 4587.4 | 2216.5 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 2901.2 | 4587.4 | 963.1 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios VYNE Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.01 | -3.09 | -1.74 | - | -2.94 | -2.63 | 1.51 | - | -0.41 | -0.39 | -0.42 | 0.55 | -0.59 | -4.83 | 3.79 | 4.17 | 0.23 | 0.19 | 0.47 | -0.76 | -0.56 | -0.36 | -0.72 | -1.8 | -1.6 | -1.21 | -1.08 | -0.96 | -0.68 | -0.72 | -0.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | -2.83 | -2.56 | -2.81 | - | -0.21 | -0.18 | -0.2 | -0.51 | -0.55 | -4.82 | -3.74 | -4.1 | -0.23 | -0.2 | -0.49 | - | -0.6 | -0.4 | -0.75 | - | -1.63 | -1.22 | -1.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-160.34 | -126.72 | -86.01 | -32.76 | -68.90 | -81.44 | -90.52 | -84.87 | -150.79 | -180.56 | -600.54 | -619.81 | -742.14 | -808.00 | -469.48 | -448.68 | -345.45 | -223.52 | -121.85 | -45.05 | -39.49 | -15.31 | 1.89 | 21.19 | 51.14 | 36.81 | 26.02 | 16.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-110.58 | -96.57 | -71.63 | -28.26 | -54.44 | -60.45 | -59.96 | -54.82 | -81.19 | -81.37 | -245.12 | -247.90 | -274.39 | -276.56 | -121.35 | -97.16 | -83.25 | -63.89 | -46.45 | -36.77 | -38.07 | -41.11 | -44.34 | -43.48 | -41.11 | -28.89 | -19.69 | -11.50 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-23.29 | -46.58 | -63.72 | -56.02 | -74.31 | -69.30 | -64.90 | -41.53 | -72.08 | -86.21 | -303.82 | -348.79 | -390.46 | -402.80 | -209.80 | -184.97 | -123.26 | -89.01 | -58.70 | -27.69 | -13.07 | 12.05 | 30.00 | 35.27 | 35.27 | 20.65 | 9.74 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.5 | 3.2 | 4.0 | 4.4 | 6.9 | 8.1 | 7.5 | 3.6 | 3.6 | 2.3 | 2.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.3 | 1.3 | 1.3 | 1.3 | 14.7 | 14.7 | 14.7 | 14.7 | 4.6 | 4.6 | 4.6 | 4.6 | 3.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
193.7 | 114.6 | 128.1 | - | 211.7 | 303.8 | 2080.8 | - | 7187.5 | 3344.2 | 5271.5 | 336.8 | 441.6 | 123.5 | 415.9 | 91.2 | - | - | 20.0 | - | 0.4 | 1.5 | 93.6 | 25.9 | 78.9 | 159.7 | 79.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | 711.1 | 939.5 | 1176.4 | 27.1 | 25.2 | 3.8 | 9.6 | - | 5.3 | 6.4 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | 769.9 | 778.8 | 627.8 | 17.5 | 16.3 | 2.4 | 9.4 | - | 15.1 | 20.0 | 19.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
193.7 | 114.6 | 128.1 | - | 211.7 | 303.8 | 2080.8 | - | 7898.6 | 4283.8 | 6447.9 | 363.9 | 466.8 | 127.3 | 425.5 | 91.2 | 5.3 | 6.4 | 23.8 | - | 0.4 | 1.5 | 93.6 | 25.9 | 78.9 | 159.7 | 79.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
193.7 | 114.6 | 128.1 | - | 211.7 | 303.8 | 2080.8 | - | 7128.7 | 3505.0 | 5820.0 | 346.4 | 450.5 | 124.8 | 416.2 | 91.2 | -9.8 | -13.6 | 3.9 | - | 0.4 | 1.5 | 93.6 | 25.9 | 78.9 | 159.7 | 79.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency